Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jul;42(7):1597-600.
doi: 10.1128/AAC.42.7.1597.

Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B

Affiliations

Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B

T Koizumi et al. Antimicrob Agents Chemother. 1998 Jul.

Abstract

We have studied the pharmacokinetics of amphotericin B (AmB) in lung lymph circulation and bronchial-wash fluid after intravenous infusion and inhalation, respectively. For two experiments with awake sheep, we used lung lymph fistulas and tracheotomy. In experiment 1, AmB concentrations in plasma and lung lymph after intravenous infusion of AmB (1 mg/kg of body weight) over 1.5 h were measured. The mean peak in plasma level was 756.0 +/- 188.8 ng/ml at 3 h after the start of infusion, and the level then decreased gradually to 194.8 +/- 28.9 ng/ml at 24 h. The stable and maximal levels in lung lymph last 5 to 9 h after the start of AmB infusion. The concentrations in lung lymph after 9 h were slightly higher than those in plasma. Thus, the lung lymph-to-plasma ratio of AmB concentrations increased gradually during infusion, and the ratio was more than 1.0 after the end of infusion, suggesting that AmB could be easily moved from plasma to pulmonary interstitium and/or lung lymph circulation. In another experiment, 5 or 30 mg of aerosol AmB was inhaled, and the concentration of AmB in the bronchial-wash fluid was determined by bronchoalveolar lavage. The peak AmB concentration in the fluid was observed at 0.5 h. After that, AmB was slowly eliminated over 24 h. The area under the concentration-time curve for 30 mg of inhaled AmB was higher than that for 5 mg, but maximum concentrations of AmB in serum for 5 and 30 mg were almost similar. These observations identify the pharmacokinetic characteristics of AmB in the lung and may provide a new insight into the strategy for clinical treatment of fungal pneumonia.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Time courses of AmB concentrations in plasma and lung lymph after drip infusion.
FIG. 2
FIG. 2
Time course of mean concentrations of AmB in plasma and lung lymph after drip infusion in four sheep. The data are means with standard deviations.

Similar articles

Cited by

References

    1. Bennett J E. Chemotherapy of systemic mycoses (first of two parts) N Engl J Med. 1974;290:30–32. - PubMed
    1. Beyer J, Barzen G, Risse R, Weyer C, Miksits K, Dullenkopf K, Huhn D, Siegert W. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 1993;37:1367–1369. - PMC - PubMed
    1. Bindschadler D D, Bennett J E. A pharmacologic guide to the clinical use of amphotericin B. J Infect Dis. 1969;120:427–436. - PubMed
    1. Block E R, Bennett J E, Livoti L G, Klein W J, MacGregor R R, Henderson L. Flucytosine and amphotericin B; hemodialysis effects on the plasma concentration and clearance. Ann Intern Med. 1974;80:613–617. - PubMed
    1. Brajtburg J, Elberg S, Bolard J, Kobayashi G S, Levi R A, Ostlund R E, Schlessinger D, Medoff G. Interaction of plasma proteins and lipoproteins with amphotericin B. J Infect Dis. 1984;149:986–997. - PubMed